Deals

Sino Biopharmaceutical's CTTQ Partners with Revvity to Launch X‑Lab Joint Shared Laboratory for Antibody Drug R&D
Chia Tai Tianqing PharmaceuticalHKG: 1177

Sino Biopharmaceutical’s CTTQ Partners with Revvity to Launch X‑Lab Joint Shared Laboratory for Antibody Drug R&D

Jiangsu Chia Tai Tianqing Pharmaceutical Co., Ltd. (CTTQ), a subsidiary of Sino Biopharmaceutical Limited (HKG: 1177), has entered into a collaboration agreement with Revvity, a global life sciences and diagnostics…

Shanghai Pharmaceuticals Renews Sales and Distribution Agreement with Fudan‑Zhangjiang Through 2029 Under RMB 272 Million Caps

Shanghai Pharmaceuticals Renews Sales and Distribution Agreement with Fudan‑Zhangjiang Through 2029 Under RMB 272 Million Caps

*Boan Biotech Out-Licenses Japan Rights to Denosumab Biosimilar BA6101 in Upfront, Milestone, and Royalty Deal

Boan Biotech Out-Licenses Japan Rights to Denosumab Biosimilar BA6101 in Upfront, Milestone, and Royalty Deal

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Mirxes

Mirxes Partners with Thailand’s N Health to Launch miRNA Cancer Screening

AcepodiaADC / XDC

Biocytogen Licenses ADC Programs to Acepodia in Option Deal

Simcere Pharma to Spin Off Zaiming Unit for Hong Kong IPO
ADC / XDCCancer

Simcere Pharma to Spin Off Zaiming Unit for Hong Kong IPO

Nona Biosciences Partners with Link Cell on CAR-T Discovery Using HCAb Platform
CAR-THBM Holdings

Nona Biosciences Partners with Link Cell on CAR-T Discovery Using HCAb Platform

Show More